Omnilink Elite 1012626-29Recalls & reported problems
Abbott Vascular Inc. · Omnilink Elite Vascular Balloon-Expandable Stent System 10.0 mm x 29 mm x 80 cm Over-The-Wire · Class 3 · Implant
All models of Omnilink Elite (42)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08717648179372), received between Oct 5, 2018 and Oct 30, 2019 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Device Dislodged or Dislocated” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Device Dislodged or Dislocated1
- Difficult to Remove1
- Off-Label Use1
Patient problems
- No Consequences Or Impact To Patient2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryOct 30, 2019Device Dislodged or Dislocated; Device Dislodged or Dislocated
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A RIGHT ILIAC ARTERY THAT WAS DISEASED. THE OMNILINK BALLOON EXPANDABLE STENT WAS BEING ADVANCED TO THE LESION, WITH NO RESISTANCE MET; HOWEVER, IT WAS NOTED THAT THE STENT SEEMED TO HAVE MOVED/COMING OFF FROM THE BALLOON. IT WAS DECIDED TO REMOVE THE SHEATH AND THE DEVICE ALTOGETHER, THEN THE STENT BECAME DISLODGED IN THE LEFT COMMON FEMORAL ARTERY. THE HOSPITAL DID NOT HAVE THE TOOLS FOR STENT REMOVAL AND THEREFORE THE PATIENT WAS TRANSPORTED TO ANOTHER HOSPITAL WHERE THE DISLODGED STENT WAS REMOVED VIA SURGICAL PROCEDURE. THE PATIENT IS FINE. THERE WAS NO ADVERSE PATIENT SEQUELA.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9258352 ↗MalfunctionOct 5, 2018Off-Label Use; Difficult to Remove; Off-Label Use; Difficult to Remove
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A DE NOVO LESION IN A MILDLY TORTUOUS SUBCLAVIAN VEIN THAT WAS 90% STENOSED. A GLIDESHEATH WAS INSERTED IN THE LEFT BRACHIAL ARTERY AND A .018 NON-ABBOTT GUIDE WIRE CROSSED THE LESION. THEN THE GUIDE WIRE WAS REPLACED WITH A .035 NON-ABBOTT GUIDE WIRE, AND PRE-DILATATION WAS PERFORMED WITH A 9.0 X 20 MM NON-ABBOTT BALLOON DILATATION CATHETER. A 10 X 29 MM OMNILINK ELITE VASCULAR BALLOON-EXPANDABLE STENT WAS IMPLANTED; HOWEVER, THERE WAS DIFFICULTY IN REMOVING THE DEVICE FROM THE INTRODUCER SHEATH. THEREFORE, THE DELIVERY SYSTEM WAS REMOVED WITH THE SHEATH AS A SINGLE UNIT. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7938786 ↗
Other STENT, ILIAC devices
- Cordis S.M.A.R.T. Control Vascular Stent System C10040MLCordis US Corp. · STENT, ILIAC1 recall3 reports
- Absolute Pro 1012534-100Abbott Vascular Inc. · STENT, ILIAC51 reports
- Protégé™ GPS™ SERB65-09-60-80Ev3, Inc · STENT, ILIAC1 recall0 reports
- Cordis S.M.A.R.T. Control Vascular Stent System C09060MLCordis US Corp. · STENT, ILIAC1 recall0 reports
- Absolute Pro 1012535-100Abbott Vascular Inc. · STENT, ILIAC1 death41 reports
- Omnilink Elite 1012631-39Abbott Vascular Inc. · STENT, ILIAC27 reports
- Omnilink Elite 1012632-29Abbott Vascular Inc. · STENT, ILIAC25 reports
- Absolute Pro 1012536-100Abbott Vascular Inc. · STENT, ILIAC21 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page